Sign in
4

Changes in Ownership

Immuneering Corp Filed Acc 0001790340-26-000082

Options or other derivatives

  • Chief Financial Officer acquired 650,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gengos Andrew · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-16 Grant or award : show line 1 in the form Stock Option +650,000 650,000 D
Loading xslF345X06/wk-form4_1784320143.xml…